CNBXOTCPharmaceutical PreparationsFiscal year ends August 31

CNBX Pharmaceuticals Inc.

Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Community

Notes and questions about CNBX Pharmaceuticals from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in CNBX Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-120 reverse split on May 12, 2022
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CNBX.

Advertisement
300 × 250